Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Revenue More Than Quadruples from Broadening Geographic Footprint and New Flower Sales to EuropeToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 28, 2026) - \PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of PharmaCielo Colombia Holdings S.A.S., Colombia's leading cultivator and producer of dried flower and food- and medicinal-grade cannabis extracts, today reported its unaudited financial results for the three months ended.
Colombian Operations Reach Cash-Flow PositiveAll figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 30, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of PharmaCielo Colombia Holdings S.A.S., Colombia's premier cultivator and producer of dried flower and food and medicinal grade cannabis and extracts for the natural pharmaceuticals and consumer products market,...
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 19, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that, as approved by the TSX Venture Exchange (the "TSXV"), it has issued 11,145,999 common shares of...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.